Ferrous Sulphate/ Manganese Sulphate/ Copper Sulphate
Indications
Registered South African indications:
- Iron deficiency anaemia
Contraindications (ZA)
Registered South African contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Patients receiving repeated blood transfusions
- Use in anaemia that is not produced by iron-deficiency unless iron-deficiency is also present
Warnings & precautions
South African recommendations
Caution in the following patients
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Elderly
- Care needed in patients with iron-storage or iron-absorption diseases, haemoglobinopathies, or existing gastro-intestinal disease
Sugar content
- Contain sucrose and dextrose; may affect glycaemic control in diabetes mellitus
- Not suitable for patients with conditions like fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency
Adult dosage (ZA)
Forms avail. in SA and covered in this monograph: tab
South African registered indications and dosages
Iron deficiency anaemia
Ferrous Sulphate/ Manganese Sulphate/ Copper Sulphate
170/2.5/2.5 (mg)
- Oral (tab): Initial: 3-5 tab, dly in divided doses; Maintenance: 2 tab, dly
To minimize side effects, tablets should be taken with or immediately after food
Paediatric dosage (ZA)
Paed. forms avail. in SA and covered in this monograph: tab
South African registered indications and dosages
Iron deficiency anaemia
Ferrous Sulphate/ Manganese Sulphate/ Copper Sulphate
170/2.5/2.5 (mg)
Younger than 6 years
- No information available
Between 6-12 years
- Oral (tab): 3 tab, dly in divided doses
Older than 12 years
- See adult dosage
To minimize side effects, tablets should be taken with or immediately after food
Pregnancy & lactation
Pregnancy
South African recommendations
- Safe
- Ferrous sulphate/ manganese sulphate/ copper sulphate can safely be used before, during and after pregnancy as iron supplementation if necessary, and if recommended by a healthcare professional
Breastfeeding
South African recommendations
- Caution
- Ferrous sulphate/ manganese sulphate/ copper sulphate is excreted through breast milk
Fertility
South African recommendations
- No information available
Renal impairment
South African recommendations
- Caution; no information available
Hepatic impairment
South African recommendations
- Caution; no information available
Elderly
South African recommendations
- Caution; no information available
Adverse reactions
Gastrointestinal Disorders
- Gastro-intestinal discomfort
- Diarrhoea
- Vomiting
- Constipation (with continued administration)
- Faeces to become black in colour
Interactions
- Tetracycline
- Antacids
Other interactions
- Tea
Monitoring
None routine. Specific cases may require
- Serum iron
Mechanism of action
Iron is an essential constituent of the body, being necessary for haemoglobin formation and for the oxidative processes of living tissue. Ferrous sulphate is one of the most widely used iron salts in the treatment of iron-deficiency anaemia.
Dosage forms
- Tablet
Formulation
Tablet 170mg
- Gulf Ferrous Sulphate Compound Tablets (Gulf)
References
1. PI - gulf_ferrous - Gulf drug company - Date of the most recent amendment to the Professional Information - 09 September 2004 - Accessed online - 05 March 2024 [https://medsinfoportal.sahpra.org.za/pi/4d03e1e4714dfb1e4d9142dc7c957540.pdf] 2. SAIDS - Medication Check - Drug Free Sport - Gulf Ferrous Sulphate compound tablets - Downloaded online 20 March 2024 [https://drugfreesport.org.za/online-medication-check/] *No matching SmPC available ** NAPOS info is a bit tricky, there is a matching ATC code, however not necessarily the combination, therefore left out
Brands & products
3 products · cached snapshot- Ferrous sulphate (syn. Ferrous sulfate)Gulf Ferrous Sulphate Compound
TABTablet· 3 products
from R27.76| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Gulf Ferrous Sulphate Compound Tablets | 170 mg;mg;mg | 30 | Gulf Drug Company (Pty) Ltd | R27.76 |
| Gulf Ferrous Sulphate Compound Tablets | 170 mg;mg;mg | 100 | Gulf Drug Company (Pty) Ltd | R92.54 |
| Gulf Ferrous Sulphate Compound Tablets | 170 mg;mg;mg | 500 | Gulf Drug Company (Pty) Ltd | R462.71 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.